Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) EPS (Basic) (2019 - 2025)

IDEAYA Biosciences (IDYA) has disclosed EPS (Basic) for 7 consecutive years, with -$0.94 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 39.35% to -$0.94 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.29 through Dec 2025, up 61.61% year-over-year, with the annual reading at -$1.28 for FY2025, 61.9% up from the prior year.
  • EPS (Basic) hit -$0.94 in Q4 2025 for IDEAYA Biosciences, down from $1.35 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $1.35 in Q3 2025 to a low of -$1.55 in Q4 2024.
  • Historically, EPS (Basic) has averaged -$0.47 across 5 years, with a median of -$0.51 in 2023.
  • Biggest five-year swings in EPS (Basic): plummeted 1250.0% in 2023 and later skyrocketed 325.0% in 2025.
  • Year by year, EPS (Basic) stood at -$0.49 in 2021, then fell by 10.2% to -$0.54 in 2022, then grew by 3.7% to -$0.52 in 2023, then plummeted by 198.08% to -$1.55 in 2024, then surged by 39.35% to -$0.94 in 2025.
  • Business Quant data shows EPS (Basic) for IDYA at -$0.94 in Q4 2025, $1.35 in Q3 2025, and -$0.88 in Q2 2025.